Roche Group’s Genentech has joined the growing ranks of pharmaceutical companies selling prescription drugs directly to patients by making its Xofluza antiviral flu medicine available through online pharmacies.
Genentech’s Direct-to-Patient (DTP) program allows patients to order the single-dose vaccine from Alto Pharmacy, Amazon Pharmacy, and Mark Cuban’s Cost Plus Drugs, San Francisco-based Genentech said on Oct. 16. Patients can order the vaccine for $50, a 70-percent reduction from its list price, Genentech said.
Ashley Magargee, the company’s CEO, said the new DTP approach allows convenient, same-day delivery of the vaccine in select U.S. markets. It also reduces the cost for uninsured patients or those with limited coverage….